Ordenar

Buscar

04/11/2025 Availability, perceived need and satisfaction for school nurses in Spain: a cross-sectional study involving the school community
Zafra-Agea, JA, Pérez, TD, Lima-Serrano, M, Vargas-Martinez, AM, Soler-Pardo, E, Torralbas-Ortega, J, Cillero, IH. Availability, perceived need and satisfaction for school nurses in Spain: a cross-sectional study involving the school community. BMC NURSING. 2025; 24(1)DOI:10.1186/s12912-025-03970-5. PMID:41188937. IF:3.900(Q1/1D).
04/11/2025 Cardiologist Attitude to Lipid Control in Patients with ASCVD without Major Cardiovascular Events: Insights from the 2024 ACS EuroPath Survey
Zaman, A, De Caterina, R, Schiele, F, Sionis, A, Catapano, A, Laufs, U. Cardiologist Attitude to Lipid Control in Patients with ASCVD without Major Cardiovascular Events: Insights from the 2024 ACS EuroPath Survey. CIRCULATION. 2025; 152(SUPPL_3)DOI:10.1161/circ.152.suppl_3.4363828. PMID:. IF:38.600(Q1/1D).
03/11/2025 Thyroid autoimmunity at onset of type 1 diabetes as a predictor of thyroid dysfunction: a thirty-years retrospective longitudinal study
Carreras, G, Mendoza, LC, Colom, C, Tirado-Capistros, M, Sardà, H, Sánchez-Quesada, JL, Pérez, A. Thyroid autoimmunity at onset of type 1 diabetes as a predictor of thyroid dysfunction: a thirty-years retrospective longitudinal study. Frontiers in Endocrinology. 2025; 16DOI:10.3389/fendo.2025.1699111. PMID:41255538. IF:4.600(Q1/3D).
03/11/2025 Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults
Torres-Esquius, S, Gabarros-Subira, M, Rivero, ME, López, GR, Mañó, LG, Lopez, F, Fernandez, C, Guijarro, F, Díaz-Beyá, M, Canela, MP, Acha, P, Jáuregui, SN, Tuset, E, Palomo, L, Valcarcel, D, Albareda, FB, Jerez, A, Montoro, MJ. Performance and clinical utility of germline genetic testing criteria for predisposition to myeloid neoplasms in adults. BLOOD. 2025; 146DOI:10.1182/blood-2025-4998. PMID:. IF:23.100(Q1/1D).
03/11/2025 Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia
Turki, A, Dall'Olio, D, Carota, L, Polizzi, S, Morote, M, Della Porta, M, Zhao, YM, Lanino, L, Sobas, M, Zhao, YQ, Sanchez, AH, Eric, S, Gimenez, LT, Abáigar, M, Elicegui, JM, Ramiro, AV, Dohner, K, Tettero, J, Esteve, J, Martinez-Lopez, J, Metzeler, K, Haferlach, T, Lehmann, S, Pratcorona, M, Thiede, C, Versluis, J, Mecklenbrauck, R, Heuser, M, Benner, A, Huntley, B, Rivas, JMH, Ossenkoppele, G, Döhner, H, Castellani, G, Bullinger, L. Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia. BLOOD. 2025; 146DOI:10.1182/blood-2025-451. PMID:. IF:23.100(Q1/1D).
03/11/2025 Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy
Torres-Esquius, S, Gabarros-Subira, M, Gurnari, C, Bravo-Perez, C, López, GR, Arias, RD, Sanz, A, Martinez, MM, Beas, F, Jáuregui, SN, Arias, R, Canela, MP, Saumell, S, Voso, MT, Maciejewski, J, Acha, P, Valcarcel, D, Jerez, A, Montoro, MJ. Bone marrow alterations and clonal hematopoiesis in germline ETV6 mutation carriers without hematologic malignancy. BLOOD. 2025; 146DOI:10.1182/blood-2025-4997. PMID:. IF:23.100(Q1/1D).
03/11/2025 First-line therapy with rituximab vs. rituximab-CHOP in post-transplant monomorphic diffuse large B-cell lymphoma (DLBCL): Long-term real-world evidence from the spanish group of lymphoma (GELTAMO)
Ubieto, AJ, Alós, DG, Dominguez, SR, Magnano, L, Sánchez, S, Vicente, FD, Iacoboni, G, Losada, CM, Manso, RG, Browne, S, Izquierdo, AR, Baumann, T, Bacelar, AG, Santaella, MP, Prieto, PG, De Villambrosia, SG, Bastos-Oreiro, M, Hernandez, AC, De Miguel, LB, Sturla, AL, Abellan, PF, Vidaller, PJP, Amutio, E, Toimil, FS, Pardal, E, Micó, M, Prat, AM, De La Cruz, B, Huerga, S, Landwehr, M, Hernández, I, Andreu, R, De la Cruz, J, Barca, EG. First-line therapy with rituximab vs. rituximab-CHOP in post-transplant monomorphic diffuse large B-cell lymphoma (DLBCL): Long-term real-world evidence from the spanish group of lymphoma (GELTAMO). BLOOD. 2025; 146DOI:10.1182/blood-2025-3677. PMID:. IF:23.100(Q1/1D).
03/11/2025 Diagnostic evaluation methods and prognostic impact of FLT3-ITD microclones in Acute Myeloid Leukemia (AML): A retrospective multicenter study on behalf of the EHA AML-specialized working group (SWG)
Gurnari, C, Ottone, T, Piciocchi, A, Späth, D, Meid, A, Marsili, G, Fabiani, E, Romano, F, Pascale, MR, Chiusolo, P, Di Ianni, M, Sobas, M, Brunetti, L, Oñate, G, Infante, JB, Nanni, J, Vetro, C, Boada, M, Candoni, A, Sierra, J, Potter, N, Gilkes, A, Johnson, S, Thomas, I, Huntley, B, Russell, N, Dillon, R, Döhner, H, Döhner, K, Voso, MT. Diagnostic evaluation methods and prognostic impact of FLT3-ITD microclones in Acute Myeloid Leukemia (AML): A retrospective multicenter study on behalf of the EHA AML-specialized working group (SWG). BLOOD. 2025; 146DOI:10.1182/blood-2025-217. PMID:. IF:23.100(Q1/1D).